Matti A Rookus

Summary

Affiliation: The Netherlands Cancer Institute
Country: The Netherlands

Publications

  1. doi request reprint The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    BMC Cancer 14:47. 2014
  2. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
  3. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
  4. doi request reprint Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 120:235-44. 2010
  5. doi request reprint Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    J Clin Epidemiol 64:1434-43. 2011
  6. pmc Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology and Biostatistics, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands
    BMJ 345:e5660. 2012
  7. doi request reprint Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Peggy Manders
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 126:193-202. 2011
  8. pmc Cancer risk in DES daughters
    Janneke Verloop
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Causes Control 21:999-1007. 2010
  9. doi request reprint Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
    Eur J Epidemiol 25:103-13. 2010

Collaborators

  • Anouk Pijpe
  • Christi J van Asperen
  • Renée L Mulder
  • Ans van den Ouweland
  • Nadine Andrieu
  • Ausrele Kesminiene
  • Pauline Slottje
  • Douglas F Easton
  • Mieke Kriege
  • Encarna B Gomez-Garcia
  • Laura J Van't Veer
  • Cora M Aalfs
  • Elisabeth Cardis
  • Bernard Peissel
  • Marie Stenmark-Askmalm
  • Ramunas Janavicius
  • Heli Nevanlinna
  • Daniela Zaffaroni
  • Theo A van Os
  • Katherine L Nathanson
  • Susan Peock
  • Paolo Radice
  • Senno Verhoef
  • Zachary Fredericksen
  • Mary B Daly
  • Georgia Chenevix-Trench
  • Theo van Os
  • Lesley McGuffog
  • Alessandra Viel
  • Jackie Cook
  • Siranoush Manoukian
  • Isabelle Mortemousque
  • Fiona Lalloo
  • D Gareth Evans
  • Conxi Lazaro
  • Sylvie Mazoyer
  • Barbara Pasini
  • Juul Wijnen
  • Louise Izatt
  • Sue Healey
  • Ignacio Blanco
  • Ana Osorio
  • Susan M Domchek
  • Peggy Manders
  • Tuomas Heikkinen
  • Antonis C Antoniou
  • Esther M John
  • Dominique Stoppa-Lyonnet
  • Fergus J Couch
  • Debra Frost
  • Anna Marie Mulligan
  • Hanne E J Meijers-Heijboer
  • Antonella Savarese
  • Margreet G E M Ausems
  • Trinidad Caldes
  • Loris Bernard
  • Ute Hamann
  • Griselda Martrat
  • Laura Ottini
  • Caroline Seynaeve
  • Paolo Peterlongo
  • Xianshu Wang
  • Rosemarie Davidson
  • Olga M Sinilnikova
  • Andrew K Godwin
  • Javier Benitez
  • Flora E van Leeuwen
  • Janneke Verloop
  • Melissa Southey
  • Xiaoqing Chen
  • Kaoru Tominaga
  • Evgeny N Imyanitov
  • Pascal Pujol
  • Encarna B Gomez Garcia
  • Jean Philippe Peyrat
  • Oskar Thor Johannsson
  • Fiona Douglas
  • Christian F Singer
  • Rosa B Barkardottir
  • Patricia A Ganz
  • Anneliese Fink-Retter
  • Amanda E Toland
  • Dorothea Gadzicki
  • Madeleine Tilanus-Linthorst
  • Frans Hogervorst
  • Hanne Meijers-Heijboer
  • Kirsten B Moysich
  • Danielle Bodmer
  • Marie Agnès Collonge-Rame
  • Noralane M Lindor

Detail Information

Publications9

  1. doi request reprint The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    BMC Cancer 14:47. 2014
    ..The study design, methods, and baseline characteristics of the cohort are described...
  2. pmc Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2
    Anna Marie Mulligan
    Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, 2 Worts Causeway, Cambridge, CB1 8RN, UK
    Breast Cancer Res 13:R110. 2011
    ..It is currently unknown how these alleles are associated with different breast cancer subtypes in BRCA1 and BRCA2 mutation carriers defined by estrogen (ER) or progesterone receptor (PR) status of the tumour...
  3. pmc Exploring the link between MORF4L1 and risk of breast cancer
    Griselda Martrat
    Translational Research Laboratory, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research IDIBELL, Gran Via 199, L Hospitalet del Llobregat 08908, Spain
    Breast Cancer Res 13:R40. 2011
    ..To gain deeper insight into this pathway and its influence on cancer risk, we searched for novel components through protein physical interaction screens...
  4. doi request reprint Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    Breast Cancer Res Treat 120:235-44. 2010
    ..Engaging in sports activity after age 30 was also inversely associated with breast cancer risk (HR = 0.63, 95%CI = 0.44-0.91). Our results indicate that sports activity may reduce the risk of breast cancer in BRCA1/2 mutation carriers...
  5. doi request reprint Validation study suggested no differential misclassification of self-reported mammography history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands
    J Clin Epidemiol 64:1434-43. 2011
    ..We assessed accuracy of self-reported lifetime mammography history by BRCA1/2 mutation carriers with and without breast cancer...
  6. pmc Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)
    Anouk Pijpe
    Netherlands Cancer Institute, Department of Epidemiology and Biostatistics, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands
    BMJ 345:e5660. 2012
    ..To estimate the risk of breast cancer associated with diagnostic radiation in carriers of BRCA1/2 mutations...
  7. doi request reprint Body weight and risk of breast cancer in BRCA1/2 mutation carriers
    Peggy Manders
    Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands
    Breast Cancer Res Treat 126:193-202. 2011
    ..Carriers may reduce their risk of postmenopausal breast cancer by maintaining a healthy body weight throughout life...
  8. pmc Cancer risk in DES daughters
    Janneke Verloop
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
    Cancer Causes Control 21:999-1007. 2010
    ..We examined long-term risk of cancer in women exposed to diethylstilbestrol (DES) in utero...
  9. doi request reprint Reliability of self-reported diagnostic radiation history in BRCA1/2 mutation carriers
    Anouk Pijpe
    Department of Epidemiology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, The Netherlands
    Eur J Epidemiol 25:103-13. 2010
    ..More consistent reporting was mainly determined by a younger age at questionnaire completion. In conclusion, inconsistent self-report of diagnostic radiation by BRCA1/2 mutation carriers was mainly non-differential by disease status...